Omiy is an AI-powered platform designed for researchers in the life sciences and biomedicine. Our system combines natural language processing, data mining, and automated analysis to streamline scientific discovery. Users can explore complex datasets, run reproducible workflows in a notebook-style environment, and receive literature-based interpretations — all in real time, with minimal coding required. Omiy empowers scientists to uncover insights faster, prioritize experiments more effectively, and accelerate innovation in areas like drug repurposing, systems biology, and personalized medicine.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Hamburg, Hamburg 20457, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://omiy.ai/
- Keywords
- baSeq.
- HQ
- Hamburg, Hamburg
Omiy Questions
Omiy's website is https://omiy.ai/
Omiy's LinkedIn profile is https://de.linkedin.com/company/omiy
Omiy has
2 employees.
View email and phone details for 2
employees at Omiy.
Omiy's industry is
Biotechnology Research
Omiy's top competitors are
Cid,
Albatross Technologies,
Leukocare Ag,
Omly,
Baseq,
Dehaze,
Seamless Therapeutics,
Awen Oncology,
Quantitative Biology Center - Qbic,
Landesbetrieb Straßen, Brücken Und Gewässer (Lsbg).
Omiy's categories are Biotechnology Research
Omiy's founding year is 2025
